Ekso's EksoNR becomes the first exoskeleton FDA-cleared for multiple sclerosis rehab

Wandercraft/EksoNR

The FDA cleared EksoNR for rehabilitation of patients with multiple sclerosis, which Ekso Bionics said made it the first exoskeleton cleared for that use. The device was already cleared for stroke and spinal cord injury (2016) and acquired brain injury (2020), and carries a European CE mark.

• 510(k) clearance for MS rehabilitation, adding a fourth condition.
• Earlier US clearances: stroke and spinal cord injury (2016), acquired brain injury (2020).
• Ekso Bionics was then based in Richmond, California; CEO Steven Sherman.